menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Despite advancements in conventional treatment modalities for non-small cell lung cancer, therapeutic options are limited and often come with severe side effects and limited efficacy. Find out how antibody-drug conjugates might be able to help address these unmet needs in non-small cell lung cancer care.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Despite advancements in conventional treatment modalities for non-small cell lung cancer, therapeutic options are limited and often come with severe side effects and limited efficacy. Find out how antibody-drug conjugates might be able to help address these unmet needs in non-small cell lung cancer care.

Facebook Comments

Schedule3 Mar 2024